Prof. Dr. Mark Slevin is a Professor of Cell Pathology at the Manchester Metropolitan University. He is also a Professor of Pathology at Targu Mures University of Medicine and Pharmacy (Romania) and Weifang University (China). He has been a Fellow of the Royal College of Pathologists since 2008. He is also a consultant for Smith and Nephew Pharmaceuticals (2012–2017) and LIPOGEMS incorporated since 2017. His research interests are focused on cell and tissue regeneration, stem cell biology, and vascular development during healing.